SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1

CUSIP: 803607AC4

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Debt / DEBT 1.250% 9/1
Market price (% of par)
120.21%
Total 13F principal
$80,563,000
Principal change
-$922,956,450
Total reported market value
$106,428,437
Number of holders
10
Value change
-$1,061,603,417
Number of buys
5
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 803607AC4?
CUSIP 803607AC4 identifies 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 as of Q1 2023

As of 31 Mar 2023, SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 was held by 10 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $80,563,000 in principal (par value) of the bond. The largest 10 bondholders included READYSTATE ASSET MANAGEMENT LP, ADVENT CAPITAL MANAGEMENT /DE/, LORD, ABBETT & CO. LLC, PUTNAM INVESTMENTS LLC, OAKTREE CAPITAL MANAGEMENT LP, MIZUHO SECURITIES USA LLC, AMUNDI, FIRST HAWAIIAN BANK, KBC Group NV, and Context Capital Management, LLC. This page lists 10 institutional bondholders reporting positions for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.